Tieron / Targeting
EDINET code list
Companies › Japanese listed company

BrightPath Biotherapeutics Co., Ltd.

ブライトパス・バイオ株式会社Tokyo Stock Exchange 4594, Pharmaceutical. Supply-chain directory entry built from public EDINET filings.

COMPANY NAME (JP)
ブライトパス・バイオ株式会社
TICKER
TSE 4594
EDINET CODE
E31851
CORPORATE NUMBER
8290001050314
INDUSTRY
Pharmaceutical (医薬品)
HEAD OFFICE
川崎市川崎区殿町三丁目25番22号

Sector risk context: supply-chain risk by country and sector.

More Pharmaceutical companies

CanBas Co.,Ltd.Carna Biosciences, Inc.Chiome Bioscience Inc.Chordia Therapeutics,IncCHUKYOIYAKUHIN CO.,LTD.Cuorips Inc.D.Western Therapeutics Institute, Inc.Daito Pharmaceutical Co., Ltd.
Screening BrightPath Biotherapeutics Co., Ltd. or mapping suppliers like them? Check any company against sanctions and forced-labor lists, free.Free sanctions check →

Work at BrightPath Biotherapeutics Co., Ltd.? Claim this page to review the data your customers see.

Get sanctions & UFLPA list updates
A short note when the lists change in ways that matter for supply-chain screening. No noise.
Sources: EDINET code list (Financial Services Agency) and the company’s own annual securities report (有価証券報告書) retrieved via EDINET. Disclosed relationships are quoted from the filing and carry its EDINET accession number; extraction is automated and conservative — anything the filing does not state is left out. Tieron does not certify, audit or endorse the company, and this page contains no Tieron risk assessment. Report an issue with this page — corrections referencing the accession number shown above are fastest to verify.